Cite

HARVARD Citation

    Tully, K. et al. (2021). Risk of Immune-related Adverse Events in Melanoma Patients With Preexisting Autoimmune Disease Treated With Immune Checkpoint Inhibitors. American journal of clinical oncology. p. . [Online]. 
  
Back to record